Evidence map›Paper›PMID 33343810›Full record

ArticleOxidative medicine and cellular longevity2020

Critical Evaluation of the Interaction of Reactive Oxygen and Nitrogen Species with Blood to Inform the Clinical Translation of Nonthermal Plasma Therapy.

Abraham Lin, Eline Biscop, Colum Breen, Stephen J Butler, Evelien Smits, Annemie Bogaerts

Abstract readEvaluation Study
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abraham LinPLASMANT-Research Group, University of Antwerp, 2601 Antwerpen-Wilrijk, Belgium.ORCID https://orcid.org/0000-0003-0097-3323
Eline BiscopPLASMANT-Research Group, University of Antwerp, 2601 Antwerpen-Wilrijk, Belgium.
Colum BreenDepartment of Chemistry, Loughborough University, LE11 3TU Loughborough, UK.
Stephen J ButlerDepartment of Chemistry, Loughborough University, LE11 3TU Loughborough, UK.ORCID https://orcid.org/0000-0001-8109-3330
Evelien SmitsCenter for Oncological Research-Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2601 Antwerpen-Wilrijk, Belgium.
Annemie BogaertsPLASMANT-Research Group, University of Antwerp, 2601 Antwerpen-Wilrijk, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-thermal plasma (NTP), an ionized gas generated at ambient pressure and temperature, has been an emerging technology for medical applications. Through controlled delivery of reactive oxygen and nitrogen species (ROS/RNS), NTP can elicit hormetic cellular responses, thus stimulating broad therapeutic effects. To enable clinical translation of the promising preclinical research into NTP therapy, a deeper understanding of NTP interactions with clinical substrates is profoundly needed. Since NTP-generated ROS/RNS will inevitably interact with blood in several clinical contexts, understanding their stability in this system is crucial. In this study, two medically relevant NTP delivery modalities were used to assess the stability of NTP-generated ROS/RNS in three aqueous solutions with increasing organic complexities: phosphate-buffered saline (PBS), blood plasma (BP), and processed whole blood. NTP-generated RNS collectively (NO

Indexed as

Blood CellsHumansPlasma GasesReactive Nitrogen SpeciesReactive Oxygen SpeciesTime FactorsTranslational Research, BiomedicalPlasma GasesReactive Nitrogen SpeciesReactive Oxygen Species

Identifiers

PMID33343810
PMCPMC7728471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.